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Introduction
The Medicines Use Review (MUR) service is an Advanced 
Service within the National Health Service (NHS) Community 
Pharmacy Contractual Framework in England and Wales, 
introduced in 2005 [1]. An MUR involves a pharmacist reviewing 
a patient’s use of their medication and is focused on improving a 
patient’s understanding and adherence to medicines, identifying 
issues and reducing medication wastage [1]. Adherence to 
medication for long-term conditions has been described by the 
World Health Organization (WHO) as “a problem of striking 
magnitude” [2]. Only 30-40% of patients are estimated to adhere 
to their prescribed medication, with poor adherence leading to 
poor health outcomes and contributing to increased hospital 
admissions and healthcare costs [2-5].
Within an MUR, pharmacists aim to provide patients 
with necessary information to improve adherence to their 
 
medication. Some evaluations of MURs have identified an 
increase in medicines’ knowledge knowledge of patients who 
have received reviews and improved confidence in managing 
their conditions [6,7]. However, the evidence that MURs improve 
health or prevent hospital admissions is ambiguous and it has 
been disputed whether MURs are worth funding [8-10]. The 
failure to find evidence of beneficial effects of MURs on these 
health outcomes has been blamed on the relatively vague criteria 
for patients to be eligible for review. Vague eligibility criteria, 
as well as pressure on pharmacists to meet annual employer 
MUR targets which is argued to often be driven by profit rather 
than patient need [11,12] is thought to have resulted in many 
pharmacists conducting reviews on patients who do not need 
one [11].
Targeted MURs were introduced in December 2011, 
requiring pharmacists to provide a proportion (currently 70%) 
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Abstract
The Medicines Use Review (MUR) Service is an Advanced Service in the community pharmacy contract in the United Kingdom (UK). It 
involves the pharmacist reviewing a patient’s use of their medication whose purpose is to improve patient understanding and adherence to 
medication and reduce medication waste. Since November 2012, the Cwm Taf University Health Board (UHB) in Wales has commissioned a 
domiciliary MUR (Dom-MUR) service, thereby providing housebound patients with equal access to MURs to those able to visit a community 
pharmacy. We aimed to identify the types of issues and interventions carried out by pharmacists as part of the Dom-MUR service. A database 
of Dom-MUR entries from December 2012 – March 2014 was obtained from the UHB. Issues and outcomes arising from Dom-MURs were 
categorised. Data was quantitatively analysed using Microsoft Excel® and GraphPad Prism®. 
Data from 194 Dom-MURs was included in the database. The mean number of issues identified per patient was 1.96 (SD±1.41). The three 
most commonly identified issues were related to ‘Patient Adherence (29%, n=110), ‘Patient Education/ Monitoring’ (21%, n=79) and ‘Medication 
Excess in Home’ (12%, n=47). The mean number of outcomes per patient was 1.97 (SD±1.48). Of the outcomes, 32% (n=122) involved the 
pharmacist contacting the GP surgery i.e. they could not resolve these issues themselves. Issues assigned to ‘Issues with Patient’s Condition’ 
were statistically less likely to be resolved by the pharmacist. The Cwm Taf UHB Dom-MUR service has the potential to be of value in terms of 
more appropriate and cost effective care. Developments within community pharmacy, such as access to patients’ health records and pharmacist 
independent prescribing, may benefit this service with the potential for pharmacists to resolve more issues themselves. 
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of MURs to patients within select target groups. In Wales, these 
include patients prescribed high-risk, anti-hypertensive or 
respiratory medications, patients prescribed a medication no 
longer needed and patients aged 85 years or over prescribed 
6 items or more. This ensures that the service is provided 
to those who will benefit most from it [13]. However, MURs 
must usually be conducted in a pharmacy consultation room, 
which is problematic for housebound patients. Telephone 
MURs are occasionally conducted with housebound patients, 
but pharmacists are not routinely expected to conduct MURs 
over the telephone and NHS approval is required each time 
[14]. Literature regarding telephone MURs is limited with no 
reports on their value. ‘Domiciliary’ pharmaceutical services 
have been described in the literature, commonly referred to 
as a Pharmacist Domiciliary Visiting Service (PDVS), targeting 
housebound patients who rely on careers to collect their 
medicines or on prescription delivery services [15-19]. It has 
been recognised that these domiciliary services are essential in 
providing equal access to pharmaceutical care, in line with the 
founding principles of the NHS, with the core principles of NHS 
Wales introduce the following statements: 
“We care for those with the greatest health need first, making 
the most effective use of all skills and resources and constantly 
seeking to fit the care and services we provide to users’ needs”. 
“We strive to improve health and remove inequities by 
working together with the people of Wales so as to ensure their 
wellbeing now and in future years and generations” [20]. 
Housebound patients are a particularly vulnerable 
demographic - often frail, elderly patients with co-morbidities 
and an associated increase in poly-pharmacy who also tend to 
have limited contact with healthcare professionals in general - 
hence there is potential for enhanced benefits from this type of 
review. Recommendations from the National Service Framework 
for Older People suggest that patients need support if they are to 
take medicines as prescribed [21]. It has also been suggested that 
carrying out reviews in patients’ homes may give pharmacists a 
clearer impression of how patients manage their medication on 
a daily basis, compared to reviews in consultation rooms or via 
telephone where pharmacists often have to rely on the patient’s 
word [22,23].
A practice-based audit was carried out in 2010-11 within 
the Cwm Taf University Health Board (UHB) on patient returned 
medicines which indicated that a number of patients rarely 
seen in the pharmacy returned a considerable number of waste 
medicines. Another audit of 21 pharmacies in the same UHB in 
2012 found that over 20% of dispensed items were delivered, 
each delivery containing an average of 5.5 items - almost double 
the average number in collected prescriptions. To investigate 
the viability of a domiciliary service, consent was gained from 
the UHB to conduct as many domiciliary visits as possible in one 
day. Fourteen patients were reviewed in their homes, and the 
information gathered from these consultations led the UHB to 
formally introducing a domiciliary MUR service.
The Domiciliary Medicines Use Review (Dom-MUR) service 
was commissioned by Cwm Taf UHB in November 2012, aiming 
to provide housebound patients equal access to MURs to those 
able to visit a pharmacy, ensuring that vulnerable patients are 
benefitting from their medicines [24]. Fifty-five pharmacies in 
the UHB were originally commissioned to provide the Dom-MUR 
service, with a payment of £26 in addition to the usual £28 MUR 
fee. Pharmacists identified eligible patients from their Patient 
Medication Records (PMR) and were required to confirm that:
The patient was responsible for administering their own 
 medication or depended upon a career• The patient was in receipt of a prescription delivery 
service and it was unreasonable for them to travel to a 
pharmacy-based MUR.
The aim of this study was to identify the types of issues and 
interventions carried out by pharmacists as part of the Cwm Taf 
UHB Dom-MUR service.
Methodology
Overview of Study Design
A secondary analysis of the Dom-MURs database using using 
Microsoft Excel® and GraphPad Prism®.
Ethical Considerations 
Cwm Taf UHB approved this research as a ‘service evaluation’ 
and ethical approval from the Cardiff School of Pharmacy and 
Pharmaceutical Sciences Research Ethics Committee was 
obtained prior to the study commencing. 
Data Collection 
Data collection using paper intervention forms for the Dom-
MURs database was undertaken by pharmacists as they made 
interventions. During Dom-MURs, pharmacists were required 
to document all interventions made, even where no actions 
were identified, and submit a copy of the action plan to the UHB 
following the review. In collaboration with the Cwm Taf UHB 
lead investigators, a database with entries from the original 
MUR documentation completed by pharmacists during Dom-
MURs between December 2012-March 2014 was obtained. 
The database was reviewed and three main identities were 
established – issues, outcomes and medication. 
Validation Stage 
Categories were assigned to issues and outcomes 
independently. Regular group discussions to ensure consistency 
increased the validity of data. The main categories used to 
assign issues are shown in (Table 1) the categories used to 
assign outcomes are shown in (Table 2). Medications involved in 
issues were classified using the chapters of the British National 
Formulary (BNF) [25].
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Table 1: Categorization of issues identified in Dom-MURs.
Main Category Description
1.1 Lifestyle
The pharmacist has noted that lifestyle 
advice was needed, for example, smoking, 
diet, vaccination.
1.2 Patient 
Education/ 
Monitoring
The pharmacist has noted that the patient 
requires education regarding their 
medication/ condition, for example storage 
of medication, inhaler technique.
1.3 Medication 
Assistance Required
The pharmacist has noted that the patient 
requires assistance with their medication, 
for example, a Monitored Dosage System 
(MDS) tray, spacer.
1.4 Patient Adherence 
Issues
The pharmacist has noted that the 
patient has issues with adherence to their 
medication/s. For example, the patient does 
not take their medication or does not take it 
according to directions prescribed.
1.5 Issues with 
Repeat Medication/
Prescription
The pharmacist has noted an issue with the 
patients repeat medication or prescription, 
for example, medication not synchronised, 
insufficient monthly quantity.
1.6 Issues with 
Patient’s Condition
The pharmacist has noted that there is 
an issue with the patient’s condition. 
For example, the patient’s symptoms are 
uncontrolled/ worsening or a new condition 
is suspected.
1.7 Issues with Use of 
Medication/
Devices
The pharmacist has noted that the patient 
currently experiences difficulty using their 
medication or device, for example due to 
packaging, formulation.
1.8 Assessment 
Required
The pharmacist has noted that the patient 
requires an assessment, for example, an eye 
check.
1.9 Issues with 
Continuity of Care
The pharmacist has noted that there is an 
issue with continuation of a patient’s current 
care, for example incomplete PMRs, unclear 
changes in treatment due to a transfer 
between care settings.
1.10 Communication/ 
Clarification
with General 
Practitioner (GP)
Needed
The pharmacist has noted that there is an 
issue regarding the clarity of a patient’s 
current treatment, for example duration of 
treatment, dose, indication.
1.11 Medication 
Excess in Home
The pharmacist has recorded that the 
patient has medication excess in the home 
that needs to be removed and/ or controlled.
1.12 No Issues
The pharmacist has carried out appropriate 
checks during the Dom-MUR but no further 
issues were recorded, or no issues were 
recorded with no checks carried out by 
the pharmacist during the Dom-MUR 
documented.
Table 2: Categorization of outcomes.
Main Category Sub-Category Description
2.1. Pharmacist-
Led
Outcomes
2.1.1. Pharmacist 
Contacted
GP Surgery
The pharmacist 
contacted the GP 
surgery to resolve the 
issue.
2.1.2. Pharmacist 
Resolved
The pharmacist was 
able to resolve the issue 
themselves, either in 
the Dom-MUR or back 
in the pharmacy.
2.2. Patient-Led
Outcomes
2.2.1. Healthcare 
Professional (HCP) 
Appointment 
Recommended
The pharmacist 
recommended that 
the patient make an 
appointment with a 
healthcare professional 
(GP, optician, nurse 
etc.) but did not make 
the appointment on the 
patient’s behalf.
2.3. No Outcomes
Documented
2.3.1. No Issue 
Identified Hence No 
Outcome
The pharmacist 
identified no issue 
hence there was no 
outcome.
2.3.2. Issue Identified 
But No Definite 
Outcome
The pharmacist 
identified an issue 
but no outcome was 
recorded.
Data Input 
Qualitative data collected from original MUR documentation 
was input into a Microsoft Excel® database by the Cwm Taf 
UHB lead investigators prior to the study commencing. The 
data included: a reference number for each patient, the issue/s 
recorded by the pharmacist, whether the issue was to be 
considered by the GP, pharmacist, patient or ‘not specified’ and 
the outcomes. 
Some rows (i.e. entries) on the original database contained 
multiple issues or outcomes and could be assigned to more 
than one category. Patients often had multiple entries in the 
database. Some patients had no issues recorded during their 
reviews, whereas some patients had issues recorded as well 
as appropriate checks (compliance etc.) documented by the 
pharmacist with no further issues. Tally charts were produced 
to display the assignment of issues, outcomes and medication to 
categories (Appendix 6).
To aid descriptive statistical analysis, a second Microsoft 
Excel® spreadsheet was produced with the reference number 
of the patient, the number of issues per patient, the number of 
outcomes per patient, the categories of issues identified (as a 
number e.g. 1.1.1.) and the categories of outcomes (as a number 
e.g. 2.1.1.). BNF chapters (as a number e.g. 2) and BNF classes 
(in words e.g. Statins) were assigned to issues where medication 
was named.
Data was also input into GraphPad Prism®. This data included 
the issues identified per category and whether pharmacists 
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could resolve the issues within those categories themselves or 
not (1=the pharmacist resolved the issue themselves, 2=the 
pharmacist did not resolve the issue themselves). 
Analysis 
Microsoft Excel® was used to calculate means, standard 
deviations and modes for the number of issues and outcomes per 
patient, as well as percentages of issue and outcome categories. 
Excel® was also used to analyze medication data, including a 
ranked list of medication categorized by BNF chapter. Graphs and 
charts displaying data were produced using Excel®. GraphPad 
Prism® was used to perform a one-way ANOVA with Tukey’s 
post-hoc test to check for statistically significant differences 
in the proportion of issues within different categories that 
pharmacists were able to resolve themselves.
Results
Issues per patient 
Figure 1: Number of issues identified per patient
Data from Dom-MURs with 194 patients was included within 
the database. (Figure 1) shows the number of issues identified 
per patient. Thirteen patients (6.7%) had no issues identified 
during their review. The remaining 181 patients had at least 
one issue identified. The mean number of issues identified per 
patient was 1.96 (SD 1.41). The most common number of issues 
identified per patient was one issue (39.69%, n=77). One patient 
had 10 issues, which was the largest number of issues identified 
per patient. Of the 13 patients who had no issues identified at all 
during their review, 4 were documented to have had appropriate 
checks carried out during the MUR (adherence etc.). The 
remaining 9 had no checks documented by the pharmacist hence 
it was impossible to determine whether the pharmacist had 
checked the patient’s adherence, understanding of medicines 
etc.
Figure 2: Proportion of issue categories identified in Dom-MURs.
Issue categories identified
The database contained a total of 380 issues, with 11 
categories of issues identified. (Figure 2) shows the proportion 
of issue categories identified in Dom-MURs. The three most 
commonly identified issues within the Dom-MURs were related 
to ‘Patient Adherence’ (29%, n=110), ‘Patient Education/ 
Monitoring’ (21%, n=79) and ‘Medication Excess in Home’ (12%, 
n=47). 
A further 28 entries fell into the category ‘1.12. No Issues’. 
Thirteen of these related to patients who had no issues identified 
during their MUR, as previously stated. The remaining 15 
entries related to patients who did have other issues recorded, 
with ‘no issue’ referring to respective checks also documented 
(adherence etc.).
BNF classification of medication
Of the total issues, 65.79% (n=250) had at least one named 
medication related. Some issues had multiple medications 
named. The total number of named medications related to issues 
was 283. (Table 3) shows a ranked list of the most common types 
of named medicines, categorized by BNF chapter. 
Table 3: Categorization of medications by BNF chapter.
Rank BNF Category
BNF 
Chapter
Number of 
Drugs (% of 
total)
Most common class of drug within the chapter
1 Cardiovascular System 2 65 (23.0) Antiplatelet Drugs and Statins1 Respiratory System 3 65 (23.0) Inhaled Corticosteroids3 Nervous System 4 53 (18.7) Opioid Analgesics
4 Gastro-intestinal System 1 35 (12.5) Proton Pump Inhibitors
5 Endocrine System 6 19 (6.7) Bisphosphonates
6 Blood and Nutrition 9 17 (6.0) Vitamin D and Analogues7 Musculoskeletal System 10 9 (3.2) NSAIDs
8 Genito-Urinary System 7 4 (1.4) Alpha-adrenoceptor Blockers
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8 Eye 11 4 (1.4) Ocular Lubricants10 Infection 5 3 (1.0) Antibacterials (Penicillins) AND Antiprotozoals AND 
Nucleoside Analogues (Antivirals)10 Skin 13 3 (1.0) Emollients10 Borderline Substances A2 3 (1.0) Nutritional Supplements13 Ear, Nose and Oropharynx 12 2 (0.7) Intranasal Corticosteroids
14
Wound Management Products 
and Elasticated Garments
A4 1 (0.4) Advanced Wound Dressings
Total Number of Medications 283
Medication could only be included in  figures if the name of the 
medication was specifically stated. For example, ‘inhalers’, whilst 
referring to a medicine, could not be classified. Cardiovascular 
and respiratory medications were most commonly related to 
issues. Antiplatelet drugs and statins were the most common 
cardiovascular medications. The most common issue related to 
both antiplatelet drugs and statins was non-adherence (46.2%, 
n=6 and 69.2%, n=9 respectively). Inhaled corticosteroids were 
the most common respiratory medication. The most common 
issue related to inhale corticosteroids was patient education: 
inhaler technique (40.7%, n=11).
Outcomes
Figure 3: Proportion of outcome types documented in Dom-MURs.
Figure 4: Reasons for pharmacists contacting GP surgeries.
The database contained a total of 383 outcomes documented 
by pharmacists. Some issues had more than one outcome 
documented. (Figure 3) shows the proportion of outcome types 
documented. The mean number of outcomes per patient was 
1.97 (SD±1.48). Fifty-seven percent (n=220) of outcomes were 
pharmacist-resolved, either during Dom-MURs or back in the 
pharmacy. Thirty-two percent (n=122) of outcomes involved 
pharmacists contacting the GP surgery i.e. they could not resolve 
these issues themselves. (Figure 4) shows a breakdown of 
reasons for pharmacists contacting the GP surgery. 
Common reasons pharmacists contacted the GP surgery 
included: to remove an item from repeat (18.03%, n=22)), 
to request the GP to review the patient/ medication (17.21%, 
n=21), to recommend changing formulation/ flavour (15.6%, 
n=19), to amend monthly medication quantity (9.02%, n=11) 
and to check patient’s notes (11.5% n=14).A further 11% (n=41) 
of outcomes were patient-led, where pharmacists recommended 
that patients make appointments with healthcare professionals 
but did not do this on their behalf. There were 7 issues identified 
by pharmacists with no definite outcomes documented hence it 
was unclear what, if anything, had been recommended to resolve 
these issues. Figure 5 shows a comparison of outcome types 
between categories of issues, taking into account the 7 issues 
with no definite outcomes recorded.
Figure 5: Comparison of outcome types between issue categories. ‘n’ 
refers to the total number of outcomes within each category of issue, not 
the number of issues within each category.
The proportion of pharmacist-resolved outcomes was 
greatest in ‘1.11. Medication Excess in Home’. The proportion 
of outcomes where pharmacists contacted the GP surgery was 
greatest in ‘1.10. Communication/ Clarification with GP Needed’. 
All outcomes within ‘1.8. Assessment required’ were patient-led, 
as pharmacists recommended all patients within this category 
make appointments with an optician. 
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Statistical analysis
To check whether there were statistically significant 
differences in the types of issues that pharmacists were able to 
resolve themselves, p-values were calculated using a one-way 
ANOVA with Tukey’s post-hoc test. The category ‘1.8. Assessment 
required’ was omitted as it contained a low number of issues 
(n=4). One-way ANOVA showed there was a highly significant 
difference in the pharmacists’ ability to resolve different types of 
issues overall (p<0.0001). 
To compare between different categories of issues, Tukey’s 
post-hoc test was utilized. Three groups were found to be 
statistically significant (p<0.05) to the rest: Issues with Patient’s 
Condition, Communication/Clarification with GP needed and 
Medication Excess in Home. 
In more detail significant differences were found between 
‘1.6. Issues with Patient’s Condition’ and ‘1.1. Lifestyle’; ‘1.2. 
Patient Education/ Monitoring’, ‘1.4. Patient Adherence’’ AND 
‘1.11. Medication Excess in Home’; ‘1.10. Communication/ 
Clarification with GP Needed’ and ‘1.1. Lifestyle’; 1.2. ‘Patient 
Education/ Monitoring’, ‘1.4. Patient Adherence’’ AND ‘1.11. 
Medication Excess in Home’; ‘1.10. Communication/ Clarification 
with GP needed’ and ‘1.3. Medication Assistance Required’ 
AND ‘1.5. Issues with Repeat Medication/ Prescription’; ‘1.11. 
Medication Excess in Home’ and ‘1.4. Patient Adherence’ AND 
‘1.5. Issues with Repeat Medication/ Prescription’. 
Statistical analysis highlights there were types of issues that 
pharmacists were less likely to resolve themselves, in particular 
issues in ‘1.10. Communication/ Clarification with GP Needed’ 
and ‘1.6. Issues with Patient’s Condition’. 
Discussion
Few domiciliary MUR services are commissioned in the UK, 
with little published data regarding the types of issues identified 
and interventions made. This is the first study to identify the 
types of issues and interventions carried out by pharmacists 
as part of a Dom-MUR service. Issues and outcomes were 
categorised and quantified, with medication classified according 
to the BNF. 
The vast majority of Dom-MURs identified at least one 
issue. The mean number of outcomes per Dom-MUR was 1.97, 
approximately three times higher than the mean number of 
outcomes per pharmacy-based MUR in the UHB (E. Williams, 
personal communication). This suggests that the service targets 
appropriate patients who are in most need of medication 
reviews, which is the predominant rationale for commissioning 
this service. This may have been aided by pharmacists being able 
to see how patients manage their medication in their homes. 
Patients may also have felt more comfortable being reviewed in 
their own homes, resulting in a more open conversation hence 
more issues being identified. 
Most research regarding MURs focus on the process rather 
than content and outcomes of reviews. The three main issues 
identified tend to be the focus of MURs. Twenty-nine percent of 
issues were related to patient non-adherence with 59% resolved 
by pharmacists. It is unsurprising that non-adherence was the 
most common issue identified. As housebound patients tend 
to have less contact with healthcare professionals, there is less 
opportunity to encourage these patients to take their medications 
as prescribed hence domiciliary visits from pharmacists 
are potentially valuable. However, a Cochrane review on 
interventions to improve adherence identified little published 
evidence on what works best [26]. Although pharmacists 
identified and may have ‘resolved’ the issue by giving advice, 
this does not mean that patients’ long-term adherence has 
improved. Follow-up studies of these patients over time would 
indicate whether adherence issues have actually been resolved 
long-term. 
Medication wastage is estimated to cost NHS Wales up to 
£50 million annually [27]. Eighty-six percent of medication 
excess issues identified were resolved by pharmacists which is 
important as intervening with medication excess helps reduce 
further wastage and NHS costs. This is likely to have been helped 
by pharmacists being able to see expired medicines and unused 
supplies unlike pharmacy-based MURs where patients often 
bring samples of what they can carry hence these issues can 
often go unnoticed [5].
Cardiovascular and respiratory medications were most 
commonly related to issues, similar to a larger pharmacy-based 
study of 1948 MURs which found that cardiovascular medications 
accounted for the largest number of medications needing action 
[11]. A large proportion of respiratory medication issues were 
related to inappropriate inhaler technique, all of which resulted 
in education by pharmacists during reviews which is important 
as inadequate technique leads to poor adherence and sub-
optimal therapy [28,29]. These medication groups are part of 
the targeted MUR eligibility criteria therefore the Dom-MUR 
service can potentially support the provision of targeted MURs.
A large proportion of issues, in particular regarding lifestyle, 
patient education and medication excess, were resolved by 
pharmacists themselves. However, there were issues that 
pharmacists were statistically less likely to resolve themselves, 
with 32% of outcomes involving pharmacists contacting GP 
surgeries. Reports in the literature comment that many GPs 
query the benefit of MURs, in particular the paperwork involved 
and the types of recommendations made by pharmacists [30]. A 
pharmacy-based MUR study found that a considerable number 
of recommendations were not subsequently auctioned by GPs 
[11]. Follow-up information of this kind was not available in 
this project. While contacting the GP is inevitable in certain 
situations, pharmacists should resolve as many issues as 
possible to relieve the burden on GP surgeries, with the Royal 
Pharmaceutical Society (RPS) stating:
“No GP should routinely be undertaking any activity which 
could, just as appropriately, be undertaken by an advanced 
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practice nurse, a clinical pharmacist or an advanced practitioner 
paramedic” [31].
The role of the pharmacist is expanding, with increasing 
prevalence of pharmacists in GP surgeries and the Common 
Ailments Service introduced in Cwm Taf UHB to cut pressures 
on GPs [32]. Of the situations where pharmacists contacted the 
GP surgery, 11.5% were to check patients’ health records, for 
example to check indications of medication. NHS England has 
supported community pharmacies in gaining access to Summary 
Care Records (SCR), enabling pharmacists to support patients 
with better-informed care and reducing the need to contact 
GPs [33,34]. An evidence review from MURs published in 2010 
found that the quality of recommendations made by pharmacists 
improves when pharmacists have more patient information 
[35]. It is hoped in the near future a similar set-up will be 
implemented for community pharmacists in Wales to access GP 
records, with the RPS stating:
“In the interest of safe and effective patient care, all 
pharmacists involved in an individual’s care should have 
appropriate read and write access to the Welsh GP record”. 
This may aid the Dom-MUR service, reducing the need for 
pharmacists to contact GP surgeries to check patients’ records. 
The RPS is also keen for pharmacists to fully utilize their 
expertise in supporting patients with long-term conditions, and 
encourage opportunities for pharmacists to become prescribers 
[31]. The 2016 Murray Review has called for a redesign of 
MURs, utilizing pharmacist independent prescribers (PIPs) to 
implement medicines optimization [36]. PIPs may be beneficial 
in developing the Dom-MUR service, with potential to further 
reduce the number of issues passed on to GPs. For example, 
15.6% of reasons for contacting GPs were to amend medication 
formulation/ flavor, which could have been resolved by PIPs. 
However, the potential of PIPs has not been exploited 
especially in the community sector. Limited funding and access 
to patient records are recognised as barriers [37], but access to 
the Welsh GP record and emphasis on pharmacists’ abilities to 
help with current pressures on GP surgeries may increase the 
prevalence of community pharmacist prescribing, potentially 
enhancing the Dom-MUR service. It is important to note however 
that PIPs should only prescribe within their competence in a 
therapeutic area. This may affect how patients are targeted for 
domiciliary visits in the UHB, with PIPs targeting patients who 
have clinical conditions within their therapeutic area.
Study limitations
This study relies on completeness of MUR documentation 
by pharmacists, who may have addressed issues during 
reviews which they failed to document. If so, this study would 
underestimate the overall number of issues identified. It is 
recognised in the literature that pharmacists may priorities 
issues to address in reviews, leaving less important issues for 
follow-up appointments [38].
The database, comprised of faithful transcriptions of original 
MUR documentation, was often vague. Some pharmacists were 
less thorough in their documentation, making categorization 
of issues difficult especially as many medications were not 
specifically named. Lack of uniformity between pharmacists 
in documenting MURs has been recognised in the literature. 
Categorization of issues introduced bias to the study due to 
their subjective nature. The vast majority of issues assigned to 
‘1.10. Clarification/ Communication with GP Needed’ could not 
be resolved by pharmacists themselves due to the nature of 
the issues. These issues could not be assigned elsewhere, but 
it could be argued that this category is an outcome rather than 
an issue. This is a unique study hence a published classification 
system to analyzed Dom-MURs was not available. Classification 
systems to analyzed pharmacy-based MURs have been published 
[38], but it was deemed that utilizing them would lead to issues 
being assigned to inappropriate categories. Discontinuation 
of domiciliary services is common [19]. A similar domiciliary 
service was piloted and subsequently withdrawn in Abertawe 
Bro Morgannwg UHB due to logistical difficulties of pharmacists 
leaving the pharmacy to conduct domiciliary visits (Morris 
A. 2017. Personal communication). It would be critical to also 
gather the views of pharmacists undertaking the Dom-MUR 
service to identify any barriers they perceive in delivering the 
service.
Conclusion
The Cwm Taf Dom-MUR service targets appropriate patients 
in need of medication reviews and this study shows that the 
service has the potential to be of value in helping housebound 
patients benefit from their medicines. Future developments 
in community pharmacy, such as increasing prevalence of 
pharmacist independent prescribing and access to patients’ 
health records, may further the potential to utilize pharmacists’ 
expertise and reduce the burden on GP surgeries to resolve 
issues identified. The opinions of pharmacists who conduct the 
service still need to be explored to supplement quantitative data 
and provide a wider evaluation of the service. 
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